 |
인쇄하기
취소
|
GSK undecided on price of Cervarix vaccine
GlaxoSmithKline has yet to decide on price, launching date and partnership of Cervarix, cervical cancer vaccine, a GSK official said on September 1.
The company is scheduled for Cervarix’s launching symposium soon but the exact date of its local supply has yet to be determined.
The official added that GSK and Green Cross Corporation have yet to settle on a co-marketing contract of Cervari...
The company is scheduled for Cervarix’s launching symposium soon but the exact date of its local supply has yet to be determined.
The official added that GSK and Green Cross Corporation have yet to settle on a co-marketing contract of Cervari...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.